Heights Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Buy
+1,500,000
New +$8.88M 2.36% 4

Other funds holding TSHA

Heights Capital Management's TSHA Position: Q2 2026 in Review

Heights Capital Management opened a new position in Taysha Gene Therapies (TSHA) in Q2 2026: 1,500,000 shares worth $10.2M. The stake represents 2.36% of the portfolio and ranks #4 among its holdings.

208 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Heights Capital Management held 1,500,000 shares of Taysha Gene Therapies worth $10.2M as of Q2 2026.
  • Taysha Gene Therapies was a new Heights Capital Management position in Q2 2026.
  • Taysha Gene Therapies made up 2.36% of Heights Capital Management's portfolio in Q2 2026, its #4 holding.
  • 208 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Heights Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.